Lung mass appearing as a dilated left ventricle on Tc-99m tetrofosmin myocardial perfusion scintigraphy.

Tc-99m tetrofosmin is a common tracer used in myocardial perfusion scintigraphy. Several benign and malignant tumors also take up tetrofosmin. We present a case of a 60-year-old woman with a history of a left lung mass awaiting resection. The patient was referred for a myocardial perfusion scan for preoperative risk assessment. The myocardial perfusion scan revealed a large cavitated lesion mimicking a dilated left ventricle and the CT scan revealed a large mass in the left lung with central necrosis displacing the heart and mediastinum. The patient underwent thoracotomy with resection of the mass and the histology confirmed atypical carcinoid. This case highlights noncardiac uptake of Tc-99m tetrofosmin in an atypical carcinoid.

[1]  J. Fitting,et al.  [Current approach to bronchial carcinoid tumors]. , 2007, Revue medicale suisse.

[2]  O. Schillaci,et al.  Mediastinal lymph node involvement in non-small cell lung cancer: evaluation with 99mTc-tetrofosmin SPECT and comparison with CT. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  O. Schillaci,et al.  The usefulness of 99mTc-tetrofosmin SPECT in the detection of intrathoracic malignant lesions. , 2003, International Journal of Oncology.

[4]  H. Schicha,et al.  Use of myocardial imaging agents for tumour diagnosis – a success story? , 2000, European Journal of Nuclear Medicine.

[5]  J R Galvin,et al.  Thoracic carcinoids: radiologic-pathologic correlation. , 1999, Radiographics : a review publication of the Radiological Society of North America, Inc.

[6]  T. Araki,et al.  Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  M. Moore,et al.  Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: in vitro studies in multidrug-resistant breast tumor cells. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  F. Smith,et al.  Technetium-99m-1,2-bis[bis(2-ethoxyethyl) phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.